250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device VC (Venture Capital) Funds in Switzerland in January 2026

A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in Switzerland. We rank investors based on the number of investments they made in Medical device companies from Switzerland. We update this investor list every month.

Top 50 Medical Device VC (Venture Capital) Funds in Switzerland in January 2026

Investor Medical Device Switzerland investments
Zürcher Kantonal Bank 24
Foundation for Innovation and Technology (FIT) 14
Verve Ventures 13
VI Partners 9
StartAngels Network 7
redalpine 5
BioMedPartners 5
OCCIDENT 5
Zühlke Ventures AG 4
Translink Capital 4
4FO Ventures 4
Fongit Seed Invest 3
415 Capital 3
EVA Basel 3
M Ventures 3
Alpana Ventures 3
Neomed Management 3
Innosuisse 3
BlueOcean Ventures 3
3wVentures 3
EIT Health 3
Ecosystem Ventures 2
Sofinnova Partners 2
Polytech Ventures 2
SICTIC 2
Initiative Capital Romandie 2
Kinled Holding 2
Inkef 2
New Enterprise Associates 2
Molten Ventures 2
TiVentures 2
Swisscom Ventures 2
Schroder Adveq 2
VitaTech S.A 2
Forward Venture Capital 1
Swiss Diabetes Venture Fund 1
Steyn Group 1
TR Invest 1
Supermoon Capital 1
Arve Capital 1
Kickfund 1
Privilège Ventures 1
Creadd Ventures 1
UZH Life Sciences Fund 1
HATCHER+ 1
Think.Health 1
SHS Capital 1
AA Sons 1
Startfeld 1
Bruker 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Zürcher Kantonal Bank VC Fund · Zürich, Zurich, Switzerland
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Series A, Funding Round
  • Switzerland, Japan, Spain
Portfolio highlights
  • BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
  • TestResults — TestResults uses the TrueTest technology and AI-based virtual user that makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. The company has simplified automated testing massively and reduced time radically. With it, the automation andmaintenance effort is reduced to a minimum that allows zero flakiness and the enlightening feeling of being in control of automation and test scenarios.
  • QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
Foundation for Innovation and Technology (FIT) VC Fund · Lausanne, Vaud, Switzerland · 10 investments in the past 12 months
The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Debt Financing, Grant, Seed
  • Switzerland, France
Portfolio highlights
  • INERGIO — This EPFL spin-off is developing faster, portable energy units that offer ten times the power at half the weight of current technology. Founder Mahmoud Hadad’s fuel cell innovation, which uses standard butane or propane that’s safe and available worldwide, offers high autonomy. INERGIO’s fuel cell geometry allows unlimited scaling, making thetechnology suitable for applications ranging from charging consumer electronics to auxiliary power for drones to automobile fuel cells. The team has a working prototype and is looking to have its minimal viable product by summer 2020 to start the pilot project with potential partners and customers.
  • Brightank — Catalyzing your Decarbonization. Brightank accelerates decarbonization with ammonia cracking catalysts, turning ammonia into fuel for heavy transport, hydrogen supply, and power. EPFL spin-off
  • DigeHealth — DigeHealth's approach to monitoring gut health using bowel noises and body measurements could provide some really valuable insights into digestive well-being.
Verve Ventures VC Fund · Zug, Zug, Switzerland
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Series A, Seed, Series B
  • Switzerland, France, Germany
Portfolio highlights
  • Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
  • Lexroom.ai — Lexroom.ai allows lawyers to complete hours of legal research in seconds.Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.Lexroom.ai perfectly integrateswith lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
  • EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
VI Partners VC Fund · Altendorf, Schwyz, Switzerland · 2 investments in the past 12 months
VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • Switzerland, Germany, United States
Portfolio highlights
  • Kadoa — AI-Powered Web Scraping Automation | No-Code, Maintenance-Free Data Extraction & Transformation
  • Buynomics — buynomics is the leading solution to optimize your product portfolio. Our clients use buynomics to optimize pricing, promotions, & portfolio architecture.
  • Unique — Unlock the power of generative AI in Finance with Unique FinanceGPT. Get custom use cases and accurate insights in a secure, enterprise-ready platform.
StartAngels Network VC Fund · Zürich, Zurich, Switzerland
StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.
Show more
Investment focus
  • Medical Device, Health Care, Medical
  • Seed, Series A, Series B
  • Switzerland, Brazil
Portfolio highlights
  • Calingo — Calingo is a digital insurance platform that offers personalised and optimised risk protection at the point of sale.
  • Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
  • Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
redalpine VC Fund · Zürich, Zurich, Switzerland
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Series A, Series B
  • Germany, Switzerland, United Kingdom
Portfolio highlights
  • Inkitt — Publish stories online, join our author subscription program, and read books online for free. Join the Inkitt community for writers and readers today.
  • Donut — Donut helps people discover new ways to build wealth, by providing the easiest and most trusted way to save & earn high yield with DeFi. Donut was founded in 2018 and is dual headquartered in Los Angeles and Berlin.
  • Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
BioMedPartners VC Fund · Basel, Basel-Stadt, Switzerland
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Switzerland, Germany, France
Portfolio highlights
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
  • TOLREMO therapeutics — TOLREMO therapeutics is striving to prevent the development of cancer therapy resistance through its proprietary drug discovery and development platform. Learn more about us.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
OCCIDENT VC Fund · Zug, Zug, Switzerland
Occident is an international, privately held investment company based in Zug and Munich. Our goal is to manage our own wealth in a sustainable, meaningful manner seeking to make a positive contribution to society through our investments. Venture Capital is the focus of our investment activities. We see ourselves as a long-term oriented enabler forinnovative start-ups and visionary founders. As a complementary team of experts, we are fascinated by technologically sound topics (deep tech) from the life sciences, digital and high-tech sectors with the potential to decisively improve people's lives.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Series B, Series C
  • Germany, Switzerland, Slovenia
Portfolio highlights
  • ReCatalyst — REvolutionizing the way we make CATALYSTs for hydrogen technologies
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Zühlke Ventures AG VC Fund · Schlieren, Zurich, Switzerland
Zühlke Ventures AG is a venture capital arm of Zühlke Technology Group AG specializing in financing of start-ups at an early stage and providing growth capital. It seeks to invest in the technology and medical devices companies. It typically invests in German-speaking Europe and Great Britain.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Seed, Series B
  • Switzerland, Sweden, United States
Portfolio highlights
  • Evismo — Evismo provides diagnostics services in Switzerland
  • Healios AG — Healios CTMS provides the Digital Biomarker based technology and digital validation scales to improve and streamline research and clinical practice.
  • Flow Neuroscience — Discover how tDCS depression treatment works. Flow Neuroscience offers a non-invasive, medical certified way to manage depression at home.
4FO Ventures VC Fund · Luxembourg, Luxembourg, Luxembourg
4FO Ventures
Show more
Investment focus
  • Artificial Intelligence, Health Care, Medical
  • Series A, Seed, Series B
  • Switzerland
Portfolio highlights
  • Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
  • Ecorobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
  • ARTIRIA Medical — Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to revolutionize the limits of neurointerventional procedures, enabling a seamless navigation and stroke treatment.
Fongit Seed Invest VC Fund · Plan-les-ouates, Geneve, Switzerland
Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Series B
  • Switzerland
Portfolio highlights
  • EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
  • Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
  • Annaida Technologies — Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
415 Capital VC Fund · Oberhaching, Bayern, Germany
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcaresystem.We are investors AND entrepreneurs: As investors, They have funded 45 MedTech companies in the past 28 years. As entrepreneurs, They have founded, built, and exited several successful European MedTech distribution companies.
Show more
Investment focus
  • Medical Device, Health Care, Medical
  • Series A, Series C, Seed
  • Switzerland, United States, France
Portfolio highlights
  • Hilo — Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom,Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com.
  • Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
EVA Basel VC Fund · Basel, Basel-Stadt, Switzerland
EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western SwitzerlandThey support start-ups by helping to bridge the gap between their business idea and the successful commercialization of their life sciences projects, innovations and technologies.They provide thorough coaching and activelyencourage contact with their wide-ranging network of experts and investors as well as providing seed-phase investments.In science and technology transfer, they act as the link between researchers, universities’ scientific liaison offices, potential investors and the market.
Show more
Investment focus
  • Biotechnology, Medical Device, Medical
  • Seed, Series A
  • Switzerland
Portfolio highlights
  • AOT - Advanced Osteotomy Tools — AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser,robotics and navigation systems to re-invent bone surgery (osteotomy).
  • POLYNEURON — Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patientswith immune disorders in a safe and effective manner.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 7 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • Biolinq — Introducing a revolutionary platform for metabolic health.
  • ChEmpower — ChEmpower is an advanced materials company that develops chemically reactive, abrasive-free planarization pads to improve chip yields and sustainability in semiconductor manufacturing.
  • Corvic AI — Corvic AI is pioneering a new era of Data-Centric AI Cognitive Infrastructure by transforming raw enterprise data into AI-ready intelligence.
Alpana Ventures VC Fund · Geneva, Geneve, Switzerland
Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.
Show more
Investment focus
  • Software, FinTech, Information Technology
  • Seed, Series A, Funding Round
  • United States, Switzerland, Germany
Portfolio highlights
  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Nezasa — Discover how to grow your business with Nezasa TripBuilder, the world's leading travel commerce solution for travel businesses.
  • Tinamu — Trusted inventory intelligence delivered in real-time
Neomed Management VC Fund · Oslo, Oslo, Norway
NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date.NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that addresssubstantial market opportunities in the pharmaceutical, medical device and diagnostics industries.NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America.From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies.NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series C, Funding Round
  • Switzerland, United States, Italy
Portfolio highlights
  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Oxular — Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
  • JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Innosuisse VC Fund · Berne, Bern, Switzerland · 18 investments in the past 12 months
Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Grant, Pre-Seed, Seed
  • Switzerland, United States, United Kingdom
Portfolio highlights
  • Hemetron — Over 100 million people globally suffer from Inflammatory Rheumatic Diseases (IRD), causing chronic pain, fatigue, and flare-ups that significantly reduce quality of life. Traditional monitoring, with doctor visits every 3-6 months, leaves gaps in tracking disease progression, leading to poor outcomes and suffering. Hemetron AG addresses thisproblem with a groundbreaking remote monitoring system, enabling patients to conduct at-home blood tests. Results are digitally sent to physicians for timely treatment adjustments. This solution improves disease tracking, patient engagement, and reduces costs. We revolutionize chronic patient care through more personalized and effective treatments, delivering better outcomes at lower costs.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
BlueOcean Ventures VC Fund · Plan-les-ouates, Geneve, Switzerland
BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • Switzerland, India, France
Portfolio highlights
  • nPloy — Simply set your filters and get matched with your dream job! Let top employers apply for you & connect with them via chat or a video call.
  • CyanoGuard AG — Our award-winning cyanide testing and optimizing solution is ideal for the mining, food, and medical field. It's easy to use, digital and offers real-time data.
  • 99RetailStreet — 99RetailStreet is an eCommerce Cloudplatform for the unorganized Retail business in the developing countries. Our ecosystem targets Retailers, Distributors, and Manufacturers. 99RetailStreet provides POS solutions to Retailers, Real-Time Analytics to Manufacturers and Distributors
3wVentures VC Fund · Herisau, Ausser-Rhoden, Switzerland
3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Angel, Series A
  • Switzerland, Spain, Austria
Portfolio highlights
  • Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
  • GUURU — GUURU is a Customer Interaction Solution that combines AI with the human experience of product users. We enable brands to provide efficient First Contact Resolution with a single platform leveraging their most proficient and dedicated customers. Contact us to find out more.
  • Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
EIT Health VC Fund · Munich, Bayern, Germany
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Grant, Pre-Seed, Seed
  • United Kingdom, Spain, Ireland
Portfolio highlights
  • IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
  • eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Ecosystem Ventures VC Fund · San Francisco, California, United States
Ecosystem Ventures, a Silicon Valley-based venture capital, offers investment and strategic consulting services to seed-stage companies.
Show more
Investment focus
  • Mobile Apps, Internet, Advertising
  • Seed, Series A, Funding Round
  • United States, India, Switzerland
Portfolio highlights
  • GeoIQ.io — ML-ready location data and no-code AI for fintech
  • SpeEdLabs — SpeEdLabs is to provide a top-notch, technology-based Learning and Practice platform to students at an affordable price, thus empowering every student to grow into their full potential.
  • Mindler — Discover your perfect career, stream, college & course with India's leading career counsellors. Career counselling & guidance programs for school, college students & graduates.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
  • AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
  • Excelsior Sciences — Rebuilding the World, From the Bottom Up
Polytech Ventures VC Fund · Lausanne, Vaud, Switzerland
Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world
Show more
Investment focus
  • Financial Services, FinTech, Software
  • Seed, Series A, Funding Round
  • Switzerland, United States, Spain
Portfolio highlights
  • yamo — Frische Bio-Kindernahrung von yamo, so lecker wie selbstgemacht und kostenlos direkt zu dir nach Hause geliefert. Jetzt probieren und profitieren.
  • Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
  • Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
SICTIC VC Fund · Zürich, Zurich, Switzerland
SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Pre-Seed, Funding Round
  • Switzerland, Germany, United Kingdom
Portfolio highlights
  • Qala — Qala delivers real-time data classification, discovery, and policy enforcement. Auto-classify sensitive data, map full lifecycles, and label at source.
  • Nextesy — Nextesy is a pioneering start-up that uses AI to simplify and automate important business processes, allowing businesses to alleviate the strain of repetitive manual procedures while increasing operational efficiency and scalability.
  • Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
Initiative Capital Romandie VC Fund
Initiative Capital Romandie is a private equity fund that focuses on technology companies based in Western Switzerland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Series E
  • Switzerland
Portfolio highlights
  • PicoDRILL — PicoDRILL generates technology leadership for its partner/customers through cutting-edge technology for drilling needs in the nanotechnology field. picoDrill is a private company located in Lausanne, Switzerland.
  • Diagnoplex — Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert Rüf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as wellas its high sensitivity and specificity.
  • Aleva Neurotherapeutics — Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity,translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor.To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage.Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use.Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.
Kinled Holding VC Fund · New York, New York, United States
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more
Investment focus
  • Biotechnology, Health Care, Financial Services
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Switzerland
Portfolio highlights
  • Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
  • OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
  • Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.
Inkef VC Fund · Amsterdam, Noord-Holland, The Netherlands
SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • The Netherlands, United States, Germany
Portfolio highlights
  • Onward — Working to restore movement, independence, and health in people with spinal cord injury.
  • Draupnir Bio — Draupnir Bio is developing new innovative therapies for patients.
  • Provable Markets — A comprehensive suite of trading & trade management solutions for the front, middle, and back office
New Enterprise Associates VC Fund · Menlo Park, California, United States
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Series B, Series C
  • United States, India, United Kingdom
Portfolio highlights
  • Wizard — Join the world's leading businesses using Wizard to sell, market, and engage their customers via text.
  • Immunomedics — Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.
  • Willow — Willow is a female technology company that develops an in-bra wearable breast pump. Its breast pumps are cordless and spill-proof. It also tracks milk output through a mobile application along with an online portal, enabling mothers to pump anywhere without hassle. The company was founded in 2014 and is headquartered in Mountain View, California.
Molten Ventures VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
Molten Ventures is a venture capital company. They invest in software, telecoms, electronics, the internet, MedTech, and cleantech services. They support visionary entrepreneurs who will invent the future.
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Series A, Series B, Funding Round
  • United Kingdom, United States, Germany
Portfolio highlights
  • BeZero Carbon — The Carbon Ratings Agency | BeZero Carbon
  • Sightline Climate — A market intelligence platform bringing clarity to the new climate economy.
  • SatVu — SatVu captures high resolution thermal data from space for a safer and more sustainable Earth.
TiVentures VC Fund · Lugano, Ticino, Switzerland
TiVenture is a seed investment fund owned by the Fondazione Centenario Banca Stato that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. TiVenture is actively looking and ready to support exceptional founders and entrepreneurs developing scalable products for the globalmarket. TiVenture has a diversified portfolio of companies and is mainly active in the life science, medical, high-tech and IT sectors.
Show more
Investment focus
  • Software, Analytics, Renewable Energy
  • Seed, Series A, Funding Round
  • Switzerland, Italy, United States
Portfolio highlights
  • Hoxell — Hoxell is an intuitive and easy-to-use integrated platform that digitizes and streamlines all hospitality operations.
  • Hive Power — Hive Power provides a SaaS platform to optimise your existing electrical distribution grid, both from the technical and economic points of view.
  • Gaia Turbine — Gaia Turbine SA - High-Performance Hydroelectric Turbine for micro and mini power plants
Swisscom Ventures VC Fund · Zürich, Zurich, Switzerland
Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Funding Round, Series B, Series A
  • Switzerland, United States, United Kingdom
Portfolio highlights
  • viboo — viboo offers self-learning predictive control on the basis of physics-informed Machine Learning as a cloud service to smart-thermostat and building automation companies.
  • Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
  • RTDT Laboratories — Make real-time decisions to optimise fleet operation through unique structural health insights
Schroder Adveq VC Fund · Zürich, Zurich, Switzerland
Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series C, Series A
  • Switzerland, United States, India
Portfolio highlights
  • Bizongo — Bizongo is a Tech-Enabled B2B Platform for Packaging, Apparels & Other Customised Goods. We digitally transform vendor management & supply chain.
  • Lenskart — Lenskart, the first of its kind online optical store in India, has made it possible to acquire a good quality pair of specs with prescription lenses for just Rs. 399, all this while you sit in the comfort of your home. With a 48-hour free home delivery guarantee and 365 days return policy, Lenskart.com is doing what e-commerce hasn’t been able todo in India yet.The website has over 500 designs of eye frames, in multiple colors, for all age groups, from Rs. 399 all the way to Rs. 4,000 for a pair. All one needs to do is select a frame, fill in their power, and place an order. You can pay online or at the time of delivery.Lenskart.com has the biggest collection of discounted contact lenses consisting of all top-notch brands (viz. Johnson & Johnson, Bausch & Lomb, Ciba Vision are to name a few) and be it disposable, toric, colored or bifocal contact lenses, you can find all possible types here. Lenskart is dedicated to providing its customers with a simple, hassle-free way to replace their contact lenses. One can receive the exact same contact lens, their doctor prescribed, delivered to their door, at a great price.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
VitaTech S.A VC Fund
VitaTech S.A
Show more
Investment focus
  • Medical Device, Biotechnology, Therapeutics
  • Series A
  • Switzerland, United States
Portfolio highlights
  • Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
  • Gain Therapeutics — Discover Gain Therapeutics' next-gen allosteric small molecule therapies, combining physics-based methods and AI to address critical patient needs.
  • Industrie Biomediche Insubri — IBI is an innovative hi-tech Swiss biomedical company focused on research, development and production of medical devices for tissue engineering and regenerative medicine: substitutes, grafts, 3D matrixes and 2D scaffolds.
Forward Venture Capital VC Fund · Den Haag, Zuid-Holland, The Netherlands
Forward Venture Capital is a Venture Capital fund that invests in early-stage companies in the US and Europe. We support early stage entrepreneurs and help them accelerate their growth.
Show more
Investment focus
  • Software, Financial Services, E-Commerce
  • Seed, Series A, Pre-Seed
  • United States, Sweden, Denmark
Portfolio highlights
  • Uniify — Uniify is a no-code customer onboarding software that makes it fast, easy and secure for financial companies to onboard their customers. Save your business time and money, and build onboarding flows for your customers in minutes instead of months.
  • Niricson — Niricson Software has developed a proprietary damage assessment software platform paired with a patent-pending drone-based data collection technology that helps infrastructure owners inspect their structures (e.g. hydro dams) in a way that is more accurate, five times faster, and 50% more cost-effective. Niricson is differentiated by its ability toautomatically detect and quantify not only surface damage, but also subsurface damage.
  • Elements Advisors — Elements Vitals revolutionize the way you measure, benchmark, and monitor financial health. Save time serving clients & growing your firm.
Swiss Diabetes Venture Fund VC Fund · Lausanne, Vaud, Switzerland
Swiss Diabetes Venture Fund is europe’s first venture fund dedicated to diabetes technology.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Funding Round
  • Norway, Sweden, Switzerland
Portfolio highlights
  • Piomic — There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems.The COMS® One Therapy System is a portable, hand-held device which incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg andfoot ulcers.The pivotal clinical study showed that the treatment is safe, leads to accelerated wound closure, overall reduced pain and increased quality of life. The easy-to-use, single button operated device integrates smoothly into the patient’s healing journey with usage in stationary and ambulant facilities but also in patient’s home.By developing a therapy which is safe and effective we hope to set a better future for patients in need.
  • GlucoSet — GlucoSet develops tools for accurate continuous glucose monitoring in Intensive Care Units, to reduce patient mortality and hospital costs.
  • BOYDSense — BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath. The company provides breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using it to diagnose and monitor chronicdiseases.It was founded in 2015 and headquartered in South San Francisco, California.
Steyn Group VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
Steyn Group is a global single family office platform that specializes in private market investments. We provide infrastructure and zero time preference capital to support emerging investment managers and businesses.
Show more
Investment focus
  • Advice, Hospital, CleanTech
  • Seed, Series A, Series B
  • United Kingdom, Switzerland, South Africa
Portfolio highlights
  • Bio-Logical — Bio-Logical offers technology to sequester carbon from agricultural waste and transform it into, climate resilience building fertiliser. This innovation is more than a product; it's a promise to regenerate land, dramatically boost crop yields, and tackle climate change head-on.
  • Enko Education — [mk_page_section bg_image="https://enkoeducation.com/wp-content/uploads/2021/03/cnp-enko-399.jpg" blend_mode="darken" bg_position="center center" bg_repeat="no-repeat" bg_stretch="true" video_color_mask="#0a0a0a" video_opacity="0.3" min_height="0" pa...
  • Carbon Capture Scotland — Carbon Capture Scotland seeks to get rid of carbon dioxide that has been organically stored in grains and barley.
TR Invest VC Fund · Tafers, Fribourg, Switzerland
Private Investment Company
Show more
Investment focus
  • Manufacturing, Software, Apps
  • Funding Round, Seed, Series A
  • Switzerland, Spain, Sweden
Portfolio highlights
  • CompPair — CompPair develops sustainable composites with an ultra-fast repair technology to extend their lifetime and reduce waste.
  • Pipra — PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess a patient's risk of suffering from cognitive disorders after surgery.
  • Fidentity — Certified identification and signing solutions from fidentity. For better conversion rates. Maximum reliability and quick time-to-market.
Supermoon Capital VC Fund · San Francisco, California, United States
Supermoon Capital is a specialist platform helping visionary founders enhance our lives, organizations, and communities through healthy sleep.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical Device
  • Seed, Series A, Funding Round
  • Switzerland, United States, Israel
Portfolio highlights
  • Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
  • Arcascope — We create mobile apps based in circadian science to help people sleep and feel better.
  • Mosanna Therapeutics — Improving the lives of patients with metabolic obstructive sleep apnea using a transformative approach
Arve Capital VC Fund
ARVE Capital
Show more
Investment focus
  • Health Care, Medical Device, Software
  • Seed
  • Germany, Switzerland
Portfolio highlights
  • Research Grid (R.grid) — Research Grid (R.grid) automates the entire clinical trial back-office by accelerating timelines and cutting admin delays. Get faster and more successful trials today.
  • Vivalyx — Vivalyx Omnisol will be a process- and cost-effective one-stop solution for all preservation applications, allowing NMP without the use of blood or human products.
  • StratifAI — Building the next generation of biomarkers for precision oncology
Kickfund VC Fund · Basel, Basel-Stadt, Switzerland
Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.
Show more
Investment focus
  • Biotechnology, Renewable Energy, Manufacturing
  • Seed, Pre-Seed, Convertible Note
  • Switzerland
Portfolio highlights
  • BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
  • Tethys Robotics — Tethys Robotics develops AI-powered application oriented robotics system that enables professionals in carrying underwater search & recovery to inspection & surveillance.
  • ASTRA Therapeutics — Astra - Therapeutics
Privilège Ventures VC Fund · Zürich, Zurich, Switzerland
Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team
Show more
Investment focus
  • Health Care, Hardware, Software
  • Seed, Series A, Funding Round
  • Switzerland, France
Portfolio highlights
  • Wyth — Wyth creates private digital spaces for virtual and hybrid audiences. With our fully customizable platform organizations can build a seamless experience and an online home for their communities to connect, learn, work, share and play without ever leaving Wyth. We give our customers full control over their brand experience, data ownership andbusiness relationships.
  • Smeetz — Smeetz is the future of a unified, data-driven and dynamic pricing-oriented commerce for attractions and cultural venues.
  • Avelo — Our mission is to save lives by bringing fast and actionable infectious disease diagnosis closer to the patient. Avelo's solution is a breath collection device. It works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia
Creadd Ventures VC Fund
Creadd Ventures is a new venture capital fund with a focus on investing Biomedical, DeepTech and SAAS companies based in Switzerland and Europe.
Show more
Investment focus
  • Medical Device
  • Seed
  • Switzerland
Portfolio highlights
  • Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
UZH Life Sciences Fund VC Fund · Zürich, Zurich, Switzerland
The UZH Life Sciences Fund involves two equal partners: the UZH Foundation and the Novartis Venture Fund. It seeks donations from private individuals, foundations and companies for the strategic priorities of the University of Zurich.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Funding Round, Seed, Convertible Note
  • Switzerland
Portfolio highlights
  • Occlufit — Occlufit is an occluder device that conforms to complex geometries and provides immediate sealing of cardiovascular defects.
  • Navignostics — Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
HATCHER+ VC Fund · Singapore, Central Region, Singapore · 5 investments in the past 12 months
Hatcher+ is a data-driven venture capital firm that uses AI and machine learning-based technologies to identify early-stage opportunities in partnership with leading accelerators and investors, worldwide.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Pre-Seed, Convertible Note
  • United States, Italy, Australia
Portfolio highlights
  • Cropify — Eliminating subjective testing from the classification process using AI and machine learning. Cropify.io
  • Flint — Introducing a new battery technology designed for sustainable energy solutions. Explore our innovation and its impact on the future of energy.
  • Cellivate Technology — Startup, with proprietary platform technologies and products that enable cellular meat companies to accelerate the growth of cells
Think.Health VC Fund · Fürstenfeldbruck, Bayern, Germany
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Seed, Series A, Series B
  • Germany, United States, Switzerland
Portfolio highlights
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
SHS Capital VC Fund · Tübingen, Baden-Wurttemberg, Germany
Mission With our investments, SHS Capital supports fast-growing companies in their mission to become European healthcare champions. Located in the …
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Funding Round, Series C, Series A
  • Germany, Switzerland, France
Portfolio highlights
  • MESI Medical — The MESI mTABLET provides predictive medical assessment with a wide selection of hardware modules, software extensions and different integration options.
  • Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
  • Simulands — Human grade cardiovascular simulators
AA Sons VC Fund · London, England, United Kingdom
Bengkulutoto hadir sebagai solusi ideal bagi para pencinta angka jitu. Dengan predikat sebagai bandar togel online terlengkap, situs ini menawarkan keunggulan berupa proses deposit super cepat, serta sistem bermain yang adil dan transparan.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Series A, Funding Round
  • France, United States, Israel
Portfolio highlights
  • HUG — Join our global creative community to showcase & sell your art, connect with others, and access creator-friendly grants and education.
  • Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
  • Multiwave Technologies — More than 2/3 of humanity has no access to medical imaging Our mission is to make MRI available globally, through our ultra-low field mobile device.
Startfeld VC Fund · Saint Gallen, Sankt Gallen, Switzerland
Startfeld is the innovation and start-up network in the St.GallenBodenseeArea. In every phase of innovation, they support both ambitious entrepreneurs and established SME, who are open to new impulses and development.
Show more
Investment focus
  • Health Care, Wellness, Manufacturing
  • Seed
  • Switzerland
Portfolio highlights
  • Nahtlos — Nahtlos is a developer of a textile ECG carrier without glue intended to provide long-term, continuous monitoring of heart activity. In order to create a modular and highly flexible ECG system, the company's device consists of a ribbon carrier with clip-in electrodes that are based on a patented electrode structure that can be easily adjustedto different body shapes. This allows doctors to increase patient comfort by swapping out the conductive gel used in gel electrodes.
  • OnlineDoctor — OnlineDoctor is an innovative Swiss-based platform that allows the user to diagnosed any skin problems quickly (within 48h), location-independent and cost-effectively by an independent dermatologist. OnlineDoctor is suitable for the evaluation of all kinds of skin problems such as rash, eczema, birthmark and many more. The company'suncomplicated, high-quality platform provides a service that benefits all parties.
  • Health Yourself — Health Yourself is making routine healthcare services available digitally and from home. So far, we are offering lab tests from home, medication subscriptions and personalised supplements for health concerns ranging from sexual health to prevention.
Bruker VC Fund · Madison, Wisconsin, United States · 2 investments in the past 12 months
Bruker Corporation is a provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series A, Funding Round, Seed
  • United States, Switzerland
Portfolio highlights
  • KIYATEC — Kiyatec is a functional precision oncology company that measures the response of individual patient live cancer cells with its innovative 3D cell culture technology platform. Kiyatec works with leading biopharmaceutical companies to unlock response dynamics for investigational drug candidates for use in solid tumors.
  • Terrain Bio — Terrain Bio helps RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, Terrain brings unparalleled speed and quality to RNA manufacturing.
  • Mercy BioAnalytics — We are making early stage cancer 100,000x easier to find using extracellular vesicles found in blood, specific to their parent cells.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Switzerland by industry